Clinical Trials · NCT03914651

CLBR Per Initial Cycle With Different Starting Dose in Aged Patients With Poor Ovarian Reservation: 300IU Versus 150IU

Phase
N/A
Recruitment status
Unknown
Sponsor
Reproductive & Genetic Hospital of CITIC-Xiangya
Enrollment
260
Start date
Apr 2019
Locations
1 site, China
Primary endpoint
Cumulative live birth rate
View Gonadorelin compound reference